Forskolin potentiates isoprenaline-induced glycerol output and local blood flow in human adipose tissue in vivo

Pharmacology and Toxicology

Volumn 81, Issue 5, 1997, Pages 214-218

  Enoksson, Staffan ^a   Blaak, Ellen ^a   Arner, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DITERPENE; FORSKOLIN; GLYCEROL; ISOPRENALINE;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD FLOW; CATHETER; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPOLYSIS; MALE; MICRODIALYSIS; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030689730     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb00049.x     Document Type: Article

References (28)

1. Ailhaud, G.: Cellular and secreted lipoprotein lipase revisited. Clin. Biochem. 1990, 23, 343-347.
2. Arner, P. & J. Bülow: Assessment of adipose tissue metabolism in man: comparison of Fick and microdialysis techniques. Clin. Sci. 1993, 85, 247-256.
3. Arner, P., J. Bolinder, A. Eliasson, A. Lundin & U. Ungerstedt: Microdialysis of adipose tissue and blood flow for in vivo lipolysis studies. Amer. J. Physiol. 1988, 255, E 737-742.
4. Arner, P., E. Kriegholm & P. Engfeldt: In situ studies of catecholamine-induced lipolysis in human adipose tissue using microdialysis. J. Pharm. Exp. Therap. 1990a, 254, 284-288.
5. Arner, P., E. Kriegholm, P. Engfeldt & J. Bolinder: Adrenergic regulation of lipolysis in situ at rest and during exercise. J. Clin. Invest. 1990b, 85, 893-898.
6. Baumann, G., S. Felix, U. Sattelberger & G. Klein: Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy - A comparative study with dobutamine and sodium nitroprusside. J. Cardiovas. Pharmacol. 1990, 16, 93-100.
7. Bernt, E. & I. Gutman: Determination of ethanol with alcohol dehydrogenase and NAD. In: Methods of enzymatic analysis. Ed.: Verlag Chemie GmbH, Weinheim, Germany, H. U. Bergmeyer. 1974, pp. 1499-1505.
8. Bristow, M. R., R. Ginsburg, W. M. Strosberg & W. Minobe: Pharmacology and inotropic potential of forskolin in the human heart. J. Clin. Invest. 1984, 74, 212-223.
9. Burns, T. W., P. E. Langley, B. E. Terry, D. B. Bylund & L. R. Forte Jr.: Comparative effects of forskolin and isoproterenol on the cyclic AMP content of human adipocytes. Life Sci. 1987, 40, 145-154.
10. Burns, T. W., P. E. Langley, B. E. Terry, D. B. Bylund & L. R. Forte Jr.: Alpha-2 adrenergic activation inhibits forskolin-stimulated adenylate cyclase activity and lipolysis in human adipocytes. Life Sci. 1982, 3, 815-821.
11. Daly, J. W., W. Padgett & K. B. Seamon: Activation of cyclic AMP-generating systems in brain membranes and slices by the diterpene forskolin: augmentation of receptor-mediated responses. J. Neurochem. 1982, 38, 532-544.
12. Dubey, M. P., R. C. Srimal, S. Nityanand & B. N. Dhawan: Pharmacological studies on coleonol, a hypotensive diterpene from coleus forskohlii. J. Ethnopharmacol. 1981, 3, 1-13.
13. 3-adrenoceptor in man. J. Clin. Invest. 1995a, 95, 2239-2245.
14. Enoksson, S., J. Nordenström, J. Bolinder & P. Arner: Influence of local blood flow on glycerol levels in human adipose tissue. Int. J. Obesity 1995b, 19, 350-354.
15. Fain, J. N., J. Adolfo Garcia-Sainz, I. Mills & J. O'Donnell: Activation of lipolysis and cyclic AMP accumulation in rabbit adipocytes by isoproterenol in the presence of forskolin or pertussis toxin. Biochem. Biophys. Acta 1984, 798, 382-389.
16. Felländer, G., B. Linde & J. Bounder: Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int. J. Obesity 1996, 20, 220-226.
17. Galitsky, J., M. Lafontan & P. Arner: Role of alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue. J. Clin. Invest. 1993, 91, 1997-2003.
18. Hellmér, J., P. Arner & A. Lundin: Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal. Biochem. 1989, 177, 132-137.
19. Hickner, R. C., H. Rosdahl, I. Borg, U. Ungerstedt, L. Jorfelt & J. Henriksson: The ethanol technique of monitoring local blood flow changes in rat skeletal muscle: implications for microdialysis. Acta physiol. scand. 1992, 146, 87-97.
20. Lebedinsky, Y., S. T. Nordstrom, S. E. Aschoff, J. F. Kapples, G. J. O'Malley, R. W. Kosley, S. Fielding & J. W. Hubbard: Cardiotonic and coronary vasodilator responses to milrinon, forskolin, and analog P87-7692 in the anesthetized dog. J. Cardiovasc. Pharmacol. 1992, 19, 779-789.
21. Lindner, E., A. N. Dohadwalla & B. K. Bhattacharya: Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from coleus forskohli. Arzneimittelforsch. Drug Res. 1978, 28, 284-289.
22. Litosch, I., T. H. Hudson, I. Mills, S. Li & J. N. Fain: Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes. Mol. Pharmacol. 1982, 22, 109-115.
23. sα. Biochemistry 1994, 33, 12852-12859.
24. Ruiz, J., Q. Shi & R. Ho: A dose-response study of forskolin, stimulatory hormone, and guanosine triphosphate analog on adenylate cyclase from several sources. Arch. Biochem. Biophys. 1986, 251, 139-147.
25. Seamon, K. B. & J. W. Daly: Forskolin: A unique diterpene activator of cyclic AMP generating systems. J. Cycl. Nucleotide Res. 1981a, 7(4), 201-224 (Mini review).
26. Seamon, K. B., W. Padgett & J. W. Daly: Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. USA 1981b, 78, 3363-3367.
27. Toshiaki, T., H. Kouichi, S. Tetsuo, A. Yasuharu, K. Hideyasu, I. Hiroshi & A. Youichi: Forskolin preferentially dilates the afferent arteriole in the canine kidney. Jap. J. Pharmacol. 1991, 55, 161-164.
28. Tossman U. & U. Ungerstedt: Microdialysis in the study of the extracellular levels of amino acids in the rat brain. Acta Physiol. Scand. 1986, 128, 9-14.